Novel SCN5A Variant in a Patient With Dilated Cardiomyopathy Complicated by Conduction Disorders and Recurrent Ventricular Arrhythmias.

Authors

Shun-Yi Shi, Li-Shang Zhai, Jing Zhu, De-Bing Tong, Yu Mao, Jun-Yu Huo, Ling Yang, Fang Jia

Published in

JACC. Case reports. Pages 110233. Sep 10, 2026. Epub Sep 10, 2026.

Abstract

Although sodium voltage-gated channel alpha subunit 5 (SCN5A) was traditionally linked to electrophysiological disorders, growing evidence underscores its significant involvement in structural abnormalities.
A young dilated cardiomyopathy patient presented with a distinctive electro-structural dual phenotype, characterized by progressive left ventricular systolic dysfunction, conduction disorders, and concomitant severe ventricular arrhythmias. Comorbidities included coronary artery disease, chronic kidney disease, obesity, and obstructive sleep apnea. Genetic testing identified a de novo heterozygous nonsense variant in the SCN5A gene. Comprehensive management included guideline-directed medical therapy for heart failure, antiarrhythmic agents, along with comorbidities management and risk factor modification.
This case highlights the diagnostic complexity of dilated cardiomyopathy in young patients with multiple overlapping etiologies-genetic, ischemic, metabolic. A de novo SCN5A variant may contribute to the arrhythmic phenotype and progressive cardiomyopathy.
Beyond its classical electrophysiological role, SCN5A is increasingly implicated in structural remodeling. This case emphasizes the complexity of genotype-phenotype correlation and gene-environment interaction.

PMID:
42886128
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.